ATRC
Price
$30.99
Change
-$0.19 (-0.61%)
Updated
May 9 closing price
Capitalization
1.45B
86 days until earnings call
INGN
Price
$6.24
Change
-$0.11 (-1.73%)
Updated
May 9 closing price
Capitalization
176.12M
93 days until earnings call
Ad is loading...

ATRC vs INGN

Header iconATRC vs INGN Comparison
Open Charts ATRC vs INGNBanner chart's image
AtriCure
Price$30.99
Change-$0.19 (-0.61%)
Volume$625.25K
Capitalization1.45B
Inogen
Price$6.24
Change-$0.11 (-1.73%)
Volume$471.56K
Capitalization176.12M
ATRC vs INGN Comparison Chart
Loading...
ATRC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATRC vs. INGN commentary
May 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATRC is a Hold and INGN is a Hold.

Ad is loading...
COMPARISON
Comparison
May 11, 2025
Stock price -- (ATRC: $30.99 vs. INGN: $6.24)
Brand notoriety: ATRC and INGN are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: ATRC: 93% vs. INGN: 150%
Market capitalization -- ATRC: $1.45B vs. INGN: $176.12M
ATRC [@Medical Specialties] is valued at $1.45B. INGN’s [@Medical Specialties] market capitalization is $176.12M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATRC’s FA Score shows that 0 FA rating(s) are green whileINGN’s FA Score has 0 green FA rating(s).

  • ATRC’s FA Score: 0 green, 5 red.
  • INGN’s FA Score: 0 green, 5 red.
According to our system of comparison, both ATRC and INGN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATRC’s TA Score shows that 3 TA indicator(s) are bullish while INGN’s TA Score has 3 bullish TA indicator(s).

  • ATRC’s TA Score: 3 bullish, 5 bearish.
  • INGN’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, both ATRC and INGN are a bad buy in the short-term.

Price Growth

ATRC (@Medical Specialties) experienced а +3.23% price change this week, while INGN (@Medical Specialties) price change was -13.33% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -1.49%. For the same industry, the average monthly price growth was +3.17%, and the average quarterly price growth was -3.96%.

Reported Earning Dates

ATRC is expected to report earnings on Aug 05, 2025.

INGN is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Medical Specialties (-1.49% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ATRC($1.45B) has a higher market cap than INGN($176M). INGN has higher P/E ratio than ATRC: INGN (71.43) vs ATRC (36.76). ATRC YTD gains are higher at: 1.407 vs. INGN (-31.952). ATRC has higher annual earnings (EBITDA): -8.11M vs. INGN (-58.34M). ATRC has more cash in the bank: 137M vs. INGN (128M). INGN has less debt than ATRC: INGN (21.9M) vs ATRC (74.5M). ATRC has higher revenues than INGN: ATRC (399M) vs INGN (316M).
ATRCINGNATRC / INGN
Capitalization1.45B176M823%
EBITDA-8.11M-58.34M14%
Gain YTD1.407-31.952-4%
P/E Ratio36.7671.4351%
Revenue399M316M126%
Total Cash137M128M107%
Total Debt74.5M21.9M340%
FUNDAMENTALS RATINGS
ATRC vs INGN: Fundamental Ratings
ATRC
INGN
OUTLOOK RATING
1..100
64
VALUATION
overvalued / fair valued / undervalued
1..100
70
Overvalued
82
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9091
PRICE GROWTH RATING
1..100
5887
P/E GROWTH RATING
1..100
9756
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ATRC's Valuation (70) in the Medical Specialties industry is in the same range as INGN (82). This means that ATRC’s stock grew similarly to INGN’s over the last 12 months.

ATRC's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as INGN (100). This means that ATRC’s stock grew similarly to INGN’s over the last 12 months.

ATRC's SMR Rating (90) in the Medical Specialties industry is in the same range as INGN (91). This means that ATRC’s stock grew similarly to INGN’s over the last 12 months.

ATRC's Price Growth Rating (58) in the Medical Specialties industry is in the same range as INGN (87). This means that ATRC’s stock grew similarly to INGN’s over the last 12 months.

INGN's P/E Growth Rating (56) in the Medical Specialties industry is somewhat better than the same rating for ATRC (97). This means that INGN’s stock grew somewhat faster than ATRC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ATRCINGN
RSI
ODDS (%)
N/A
Bullish Trend 3 days ago
69%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
72%
Bearish Trend 3 days ago
76%
Momentum
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 3 days ago
74%
MACD
ODDS (%)
Bearish Trend 3 days ago
76%
Bearish Trend 3 days ago
69%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
73%
Bearish Trend 3 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
72%
Bearish Trend 3 days ago
83%
Advances
ODDS (%)
Bullish Trend 4 days ago
73%
Bullish Trend 5 days ago
72%
Declines
ODDS (%)
Bearish Trend 11 days ago
84%
Bearish Trend 3 days ago
83%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 3 days ago
66%
Aroon
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
86%
View a ticker or compare two or three
Ad is loading...
ATRC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ANAVX21.010.21
+1.01%
Virtus NFJ International Value R6
FGGBX2.560.01
+0.39%
Templeton Global Balanced R6
JVMSX26.500.08
+0.30%
JHancock Disciplined Value Mid Cap R2
JUSYX16.17-0.02
-0.12%
JPMorgan US Small Company R5
FTXFX41.82-0.30
-0.71%
FullerThaler Behavioral Sm-Cp Gr R6

ATRC and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATRC has been loosely correlated with NVST. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if ATRC jumps, then NVST could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATRC
1D Price
Change %
ATRC100%
-0.61%
NVST - ATRC
40%
Loosely correlated
-1.01%
SIBN - ATRC
39%
Loosely correlated
+0.87%
ICUI - ATRC
39%
Loosely correlated
-3.20%
IRMD - ATRC
38%
Loosely correlated
-1.54%
QTRX - ATRC
37%
Loosely correlated
-4.17%
More

INGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, INGN has been loosely correlated with VCYT. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if INGN jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INGN
1D Price
Change %
INGN100%
-1.73%
VCYT - INGN
45%
Loosely correlated
-4.81%
STRRP - INGN
44%
Loosely correlated
N/A
OSUR - INGN
38%
Loosely correlated
-3.46%
ITGR - INGN
33%
Poorly correlated
-0.90%
MYGN - INGN
32%
Poorly correlated
-3.47%
More